Rapid Dose Therapeutics Announces Grant of Incentive Stock Options and the Issuance of Warrants

Written by Customer Service on . Posted in Public Companies.

BURLINGTON, Ontario, March 30, 2021 (GLOBE NEWSWIRE) — Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), announces, pursuant to its Stock Option Plan, the granting of incentive stock options to purchase 4,490,000 common shares at an exercise price of $0.24 per share. Each has a term of 2 years and vests equally every six months over the term. The grant of options is subject to the policies, and acceptance by, the Canadian Securities Exchange.

In addition, the Company announces, pursuant to an advisory agreement, the issuance of 200,000 Share Purchase Warrants having an Exercise Price of $0.24 per share for a two year term ending March 28, 2023.

Further, the Company announces, pursuant to an investment and public relations services agreement, the issuance of 200,000 Share Purchase Warrants having an Exercise Price of $0.24 per share for a two year term ending March 28, 2023.

About RDT

Rapid Dose Therapeutics Corp. is a publicly-traded Canadian life sciences company providing innovative, proprietary drug delivery technologies designed to improve outcomes and quality of lives. RDT offers Quick, Convenient, Precise and Discreet™ choices to consumers. RDT is focused and committed to clinical research and product development for the healthcare manufacturing industry — including nutraceutical, pharmaceutical and cannabis industries. RDT is committed to continually create innovative solutions for humans, animals, and plants.

For more information, visit: www.rapiddose.ca

For inquiries please contact:

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.